ArticleBMC psychiatry2026
Assessing anhedonia in Chinese healthy and depressed adolescents: reliability, validity, and clinical utility of the anhedonia scale for adolescent.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Family communication patterns and adolescent depressive symptoms: sequential mediating effects of hedonic capacity and anger expression.Frontiers in psychology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnhedonia, a core symptom of adolescent depression, is often difficult to assess, the 14-item Anhedonia Scale for Adolescents (ASA) was developed to address this need. This study aimed to evaluate the reliability and validity of the ASA among healthy and depressed adolescents in China.
methodsIn Study 1, a large community sample of 1,448 adolescents (female = 855; mean age = 14.61 years) from middle schools across eastern, western, and central China were recruited between October 2022 to April 2023 to evaluate the psychometric properties of the ASA in general population. To validate the factor structure, confirmatory factor analysis was employed. Internal consistency (Cronbach's α) and test-retest reliability at six-month intervals (Intraclass Correlation Coefficient, ICC) were also assessed. In Study 2, a clinical sample of 168 adolescents with major depressive disorder (MDD), 121 with subthreshold depression (SD), and 149 healthy controls (HC) were recruited between April 2023 to April 2024, to examine the construct validity, discriminative ability, and clinical applicability and divergent validity of the ASA. One-way analyses of variance (ANOVAs) were conducted to analysis the group difference.
resultsIn Study 1, validity assessments confirmed that a three-factor model - (1) Enjoyment, Excitement, Emotional Flattening; (2) Enthusiasm, Connection, Purpose; (3) Effort, Motivation, Drive-provided a good fit. Reliability assessments demonstrated strong internal consistency (Cronbach's α = 0.733 to 0.883) and test-retest reliability (ICC = 0.749). In study 2, the ASA exhibited acceptable reliability and validity within the MDD group. Crucially, ANOVA results revealed significant group differences in ASA scores, with MDD patients scoring the highest, followed by SD groups, and then HCs (MDD > SD >HC, ps < 0.001), demonstrating strong discriminative ability.
conclusionsThese results indicate that the ASA demonstrates acceptable construct validity, reliability, discriminative ability and shows promise as a useful tool for assessing anhedonia in Chinese adolescents for both research and clinical settings with Chinese adolescents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.